SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Downloaden Sie, um offline zu lesen
Medical Journal of the
Islamic Republic ofIran
Volwne 13
Nwnber3
Fall 1378
November 1999
ANTIOXIDANT VITAMINS IN DIABETES
A. KHANAM, Ph.D.
From the Department ofBiochemistry, University ofKarachi, Karachi-75270, Pakistan.
ABSTRACT
The study included nineteen control subjects and fifty-nine diabetic patients.
The diabetic patients were divided according to the treatment they received. Fasting
blood glucose was markedly increased in all three groups, while low serum vitamin
A, C and E levels were observed in diabetic patients as compared to control subjects.
MJIRI, Vol. 13, No.3, 175-177, 1999
INTRODUCTION
Diabetes mellitus is a chronic disorder of carbohydrate,
fatandproteinmetabolism,characterizedbyan inappropriate
elevation of the blood glucose level, for which a relative or
absolute lack of insulin is reponsible.1
The role of oxidant stress in the causation of chronic
tissue damage is being recognized. Oxidant stress is usually
countered by an abundant supply of antioxidants. Vitamin
E and C levels are markedly lower in diabetic patients.
There is a paradoxical rise in catalase and glutathione
peroxidase (Gpx)in diabeticpatients withretinopathy. This
may be a compensatory mechanism by the body to prevent
tissue damage by increasing thelevels of the two alternative
antioxidant enzymes.2 Vitamin A blood concentration was
significantly decreased in type-I and increased in type-IT
diabetic patients as compared to control subjects.3
In pathologic conditions such as diabetes, oxidative
stress causes the level of antioxidants to fall below normal.4
Treatment with antioxidants can reduce both oxidative
stress and protein glycation and may help to reduce the risk
of developing diabetic complications. Ascorbate has both
pro-oxidant andantioxidanteffects in vivo.5 Chronic vitamin
C administration has a beneficial effect upon glucose and
lipid metabolism in aged non-insulin dependent diabetic
patients.6 Vitamin E and C levels are markedly lower in
diabetic patients.2
Vitamin E delays the oxidative process which turns
cells "rancid" and it prevents oxygen from combining with
other substances to form the deadly hydrogen peroxide
which hastens the death of a cell. VitaminE administration
is useful for the prevention of diabetic complications.7
175
MATERIAL AND METHODS
Blood samples from pre-diagnosed diabetic patients
were collected after12hours of fasting and discontinuation
of antidiabetic drugs. For control, the blood samples were
obtained from healthy individuals having no symptoms or
history of diabetes. Blood was analyzed for glucose,8
ascorbic acid,9 �-carotene, serum retinol and serum c£­
tocophero1.1o
RESULTS
The study included 19 controls (10 male, 9 female)
having a mean age of 24.5± 0.6 years and mean weight of
60.5±2.2 kg; the prediagnosed 59 diabetic patients (29
male, 30 female) had a mean age of 49.6±1.7 years and
mean weight of 65.7±2.3 kg.
The diabetic patients showed higher levels of blood
glucose and lower levels of blood ascorbic acid and serum
�-carotene, retinol and vitamin E as compared to normal
control subjects (Table1).Thediabeticpatients werefurther
categorized as patients on diet control, patients on oral
hypoglycemic drugs, and patients on insulin therapy. All
three groups of diabetic patients showed a higher level of
blood glucose and lower level of serum �-carotene, retinol
and vitamin E, and blood vitamin C as compared to control
patients (Table II).
DISCUSSION
The most common and diagnostic character of diabetic
patients is ahighfasting bloodsugar level, i.e.hyperglycemia,
Antioxidant Vitamins in Diabetes
Table I. Blood glucose, �-carotene, retinol, vitamin C and Vitamin E levels
in control and diabetic patients.
Group Blood b-Carotene Retinol Vitamin C Vitamin E
glucose (mg/L) (mg/L) (mg/dL) (mg/L)
(mg/dL)
Control 87.05 1.43 0.66 2.96 10.31
±5.42 ±O.10 ±0.01 ±0.23 ±0.24
(19) (19) (19) (19) (19)
Diabetics 262.52* 0.61* 0.33* 1.23* 5.77*
±16.01 ±0.03 ±0.01 ±0.O5 ±0.21
(59) (59) (59) (59) (59)
* p<0.05, statistically significant as compared to �ntrol subjects.
Table II. Blood glucose, �-carotene, retinol, vitamin C and vitamin E levels in
control and diabetic patients according to the method of blood sugar control.
Group Blood b-Carotene
glucose (mg/L)
(mg/dL)
Control 87.05 1.43
±5.42 ±0.09
(19) (19)
Patients 242.0* 0.70*
on diet ±43.31 ±0.09
control (6) (6)
PatientS on 263.37* 0.66*
oral hypo- ±27.06 ±0.04
glycemic (27) (27)
drugs
Patients 249.07* 0.57*
on insulin ±17.93 ±0.04
therapy (26) (26)
* p<0.05 as compared to control.
caused by insufficient availability of insulin or inadequate
insulin activity in the body.ll
The majorityofdiabetic patients sufferwithneuropathy,
nephropathy, and ocular complications. Vitamin A, E and C
are antioxidants and their lack may cause many of such
complications. Salonen12reported that freeradical stress has
a role in the causation of non-insulin dependent diabetes
mellitus.
Martinolil3 showed that plasma retinol is significantly
decreased in insulin dependent diabetic patients while n­
tocopherol is significantly altered in diabetic patients with
nephropathy. Cabellerol4 reported that vitamin E
supplementation produced a significant improvement in
176
Retinol Vitamin C Vitamin E
(mg/L) (mg/dL) (mg/L)
0.66 2.96 10.31
±0.09 ±0.23 ±0.24
(19) (19) (19)
0.36* 1.14* 6.10*
±0.03 ±0.15 ±0.86
(6) (6) (6)
0.32* 1.35* 6.12*
±0.02 ±0.08 ±0.29
(27) (27) (27)
0.34* 1.13* 5.41*
±0.02 ±0.03 ±0.27
(26) (26) (26)
glucose utilization and the hepatic response to insulin in
normal and diabetic subjects. The vitamin A level was also
significantly lowered as compared to control subjects,
comparable to the results of Martinoli.13
In the present study vitamin C and E levels in the blood
were lower in diabetic patients as compared to control
subjects. Rema et aU had also found similar results. The
reason may be that the high glucose concentration reduces
D-n-tocopherol binding through mechanisms independent
of osmotic effects of sorbitol accumulation in the cell. A
glucosemediatedreductionin D-n-tocopherolbindingcould
diminish the beneficial effects of D-n-tocopherol on the
vascular toxicity of hyperglycemia in diabetes mellitus.IS
A. Khanam, Ph.J?
It is concluded that diabetic patients having elevated
fasting blood glucose levels are at risk of lack ofantioxidant
vitamins, and the deficiency of these vitamins may lead to
further complications. It is therefore recommended that
diabeticpatients consume dietswhich are richinantioxidant
vitamins.
REFERENCES
1. GenuthS: A case for blood glucosecontrol. Adv Int Med 40:
573-623,1995.
2. Rema M,Mohan V,Bhashar A,Shanmugasundarm KR:Does
oxidant stress play a role in diabetic retinopathy? Indian J
OphthalmoI43(1): 17-21,1995.
3. Krempf M,Ranganthan S,Ritz P,Marin M,Charbonnel B:
Plasma vitamin A and E in type-I and type-II adult diabetic
patients. IntJ Vitam Nutr Res 61(1): 8-12,1991.
4. Sardesai V M:Role of antioxidants in healthmaintenance.Nutr
Clin Pract 10 (1): 19-25,1995.
5. YoungIS,TateS,LightbodyJ H,McMasterD,TrimpleR: The
effect of desferrioxamine and ascorbate on oxidative stress in
the streptozotocin diabetic rat. Free-Radic Bio Med 18 (5):
833-834,1995.
6. Paolisso G,Balibo V,Volpe C,Varricchio G,Gambardella A,
Saccomanno F,Ammondola S,Varricchio M,D'Onofrio F:
Metabolic benefits deriving from chronic vitamin C
supplementation in aged non-insulin dependent diabetes. J
Am CoIl Nutr 14(4); 387-392,1995.
7. Ceriello A,Gingliano D,Quatrano A,Donzell C,Dipalo G,
177
Lefebvre PJ: Vitamin E reduction of protein glycosylation in
diabetes. New prospects for prevention of diabetic
complications. Diabetes Care 14(1): 68-72,1991.
.
8. Dubowski K M: An O-toluidine method for body fluidglucose
det�rmination. Clin Chern 8: 215-235,1962.
9. Vadey H: Practical Biochemistry,4th ed. Published by Gulab
Vam-ani for Arnold-Heinemann,New Delhi,1969.
10. McMurrayW, Gowenlock A H: Vitamins. In: GowenlockAI:J,
McMurray JR, Malauchan DM, (eds.), Varley's Practical
Clinical Biochemistry. 6th ed,London: Heinemann Medical
Books, pp. 895,902,1988.
11. Jamal S: Etiology of diabetes. Diabetes Digest 2(i): 11-15,
1989.
12. Salonen IT, Nyyssonen K, Tuomoinen TP, Maenpaa PH,
Koipela H,Kaplan GA, Lynch J,Helmrich SP,Salonen R:
Increased risk of non-insulin dependent diabetes mellitus at
low plasma vitamin E concentration. Br Med J 311 (7013):
1124-1127,1995.
13. Martinoli L,Di Felice M,Seghieri G,Ciuti M,De Giorgoi LA,
FazZini A,Gori R,AnichiniR,Franconi F: Plasma retinol and
a-tocopherol concentrations in insulin dependent diabetes
mellitus: their relationship to microvascular complications.
IntJ Vit NutrRes 63(2): 87-92,1993.
14. Cabellero B: Vitamin E improves the action of insulin. Nutr
Rev. 51 (11): 339-340,1993.
15. Kunisaki M,Umeda F,Yamauchi T,Masakado M,Nawata H:
High glucose reduces specific binding for D-a-tocopherol in
cultural aortic endothelial cells. Diabetes 42(8): 1138-1146,
1993.
ANTIOXIDANT VITAMINS IN DIABETES

Weitere ähnliche Inhalte

Was ist angesagt?

Ueda2015 canagliflozin dr.inass shaltout
Ueda2015 canagliflozin dr.inass shaltoutUeda2015 canagliflozin dr.inass shaltout
Ueda2015 canagliflozin dr.inass shaltout
ueda2015
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy management
Naresh Monigari
 
Underlying pathophysiology in diabetes
Underlying pathophysiology in diabetesUnderlying pathophysiology in diabetes
Underlying pathophysiology in diabetes
Dr. Lin
 

Was ist angesagt? (20)

Oral hypoglycemics in ckd
Oral hypoglycemics in ckd Oral hypoglycemics in ckd
Oral hypoglycemics in ckd
 
ueda2012 comparison of glibenclamide and mtaformin_d.ma_mostafa abdel khalek.
ueda2012 comparison of glibenclamide and mtaformin_d.ma_mostafa abdel khalek.ueda2012 comparison of glibenclamide and mtaformin_d.ma_mostafa abdel khalek.
ueda2012 comparison of glibenclamide and mtaformin_d.ma_mostafa abdel khalek.
 
Diabetes management in hemodialysis by prof alaa wafa
Diabetes management in hemodialysis by prof alaa wafaDiabetes management in hemodialysis by prof alaa wafa
Diabetes management in hemodialysis by prof alaa wafa
 
Iatrogenic diabetes
Iatrogenic diabetesIatrogenic diabetes
Iatrogenic diabetes
 
Ueda2015 canagliflozin dr.inass shaltout
Ueda2015 canagliflozin dr.inass shaltoutUeda2015 canagliflozin dr.inass shaltout
Ueda2015 canagliflozin dr.inass shaltout
 
Safety and Efficacy of Sulfonylurea Drugs in Type 2 Diabetes Mellitus
Safety and Efficacy of Sulfonylurea Drugs in Type 2 Diabetes MellitusSafety and Efficacy of Sulfonylurea Drugs in Type 2 Diabetes Mellitus
Safety and Efficacy of Sulfonylurea Drugs in Type 2 Diabetes Mellitus
 
Incidence Of Micro-Albuminura In Diabetes Mellitus Type 2; A Prospective Stud...
Incidence Of Micro-Albuminura In Diabetes Mellitus Type 2; A Prospective Stud...Incidence Of Micro-Albuminura In Diabetes Mellitus Type 2; A Prospective Stud...
Incidence Of Micro-Albuminura In Diabetes Mellitus Type 2; A Prospective Stud...
 
Study of Ischemia Modified Albumin in Type 2 Diabetes as a Marker of Severity
Study of Ischemia Modified Albumin in Type 2 Diabetes as a Marker of SeverityStudy of Ischemia Modified Albumin in Type 2 Diabetes as a Marker of Severity
Study of Ischemia Modified Albumin in Type 2 Diabetes as a Marker of Severity
 
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHYDIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY
 
Type II Diabetes Poster
Type II Diabetes PosterType II Diabetes Poster
Type II Diabetes Poster
 
Metformin
MetforminMetformin
Metformin
 
Diabetes,dysglycemia; and chronic kidney disease by prof alaa wafa
Diabetes,dysglycemia; and chronic kidney disease by prof alaa wafaDiabetes,dysglycemia; and chronic kidney disease by prof alaa wafa
Diabetes,dysglycemia; and chronic kidney disease by prof alaa wafa
 
Clinical aspects of diabetes prof alaa wafa
Clinical aspects of diabetes prof alaa wafaClinical aspects of diabetes prof alaa wafa
Clinical aspects of diabetes prof alaa wafa
 
B04120609
B04120609B04120609
B04120609
 
Management of coronary disease in diabetes - Is it different?
Management of coronary disease in diabetes - Is it different?Management of coronary disease in diabetes - Is it different?
Management of coronary disease in diabetes - Is it different?
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy management
 
Dislipidemia no dm2 insulina x oad
Dislipidemia no dm2 insulina x oad Dislipidemia no dm2 insulina x oad
Dislipidemia no dm2 insulina x oad
 
Underlying pathophysiology in diabetes
Underlying pathophysiology in diabetesUnderlying pathophysiology in diabetes
Underlying pathophysiology in diabetes
 
Controversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitusControversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitus
 
Metformin
MetforminMetformin
Metformin
 

Andere mochten auch

Andere mochten auch (7)

Терминологическое исследование: моральный вред vs Personal injury
Терминологическое исследование: моральный вред vs Personal injuryТерминологическое исследование: моральный вред vs Personal injury
Терминологическое исследование: моральный вред vs Personal injury
 
Primer TRIM: Finanzas Públicas nacionales volvieron al Banco.
Primer TRIM: Finanzas Públicas nacionales volvieron al Banco.Primer TRIM: Finanzas Públicas nacionales volvieron al Banco.
Primer TRIM: Finanzas Públicas nacionales volvieron al Banco.
 
SlideShare
SlideShareSlideShare
SlideShare
 
Informe Energético a Febrero de 2016 por provincias
Informe Energético a Febrero de 2016 por provinciasInforme Energético a Febrero de 2016 por provincias
Informe Energético a Febrero de 2016 por provincias
 
VeloPlay device - Low-fidelity Model
VeloPlay device - Low-fidelity ModelVeloPlay device - Low-fidelity Model
VeloPlay device - Low-fidelity Model
 
The Four Year Career Plan
The Four Year Career PlanThe Four Year Career Plan
The Four Year Career Plan
 
«КОЗАЦЬКОМУ РОДУ НЕМА ПЕРЕВОДУ…»
«КОЗАЦЬКОМУ РОДУ НЕМА ПЕРЕВОДУ…»«КОЗАЦЬКОМУ РОДУ НЕМА ПЕРЕВОДУ…»
«КОЗАЦЬКОМУ РОДУ НЕМА ПЕРЕВОДУ…»
 

Ähnlich wie ANTIOXIDANT VITAMINS IN DIABETES

diabetes mellitus.pptx
diabetes mellitus.pptxdiabetes mellitus.pptx
diabetes mellitus.pptx
DrAakankshaSharma1
 
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
iosrjce
 
Healthy Effects Of Quercetin
Healthy Effects Of QuercetinHealthy Effects Of Quercetin
Healthy Effects Of Quercetin
Dr Tarique Ahmed Maka
 
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity SurgeryResolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
George S. Ferzli
 

Ähnlich wie ANTIOXIDANT VITAMINS IN DIABETES (20)

diabetes mellitus.pptx
diabetes mellitus.pptxdiabetes mellitus.pptx
diabetes mellitus.pptx
 
Microalbuminuria And Serum Creatinine Levels In Diabetic And Non Diabetic Gro...
Microalbuminuria And Serum Creatinine Levels In Diabetic And Non Diabetic Gro...Microalbuminuria And Serum Creatinine Levels In Diabetic And Non Diabetic Gro...
Microalbuminuria And Serum Creatinine Levels In Diabetic And Non Diabetic Gro...
 
1. Insuline and Anti diabetics
1. Insuline and Anti diabetics1. Insuline and Anti diabetics
1. Insuline and Anti diabetics
 
Actos
ActosActos
Actos
 
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbahueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
ueda2013 dpp-4 inhibitors “vildagliptin” -d.mesbah
 
Bydureon
BydureonBydureon
Bydureon
 
Abcc1
Abcc1Abcc1
Abcc1
 
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
Cystatin C as a marker of Cardio metabolic disorder in obese South Indian ind...
 
Acute complications of diabetes mellitus
Acute complications of diabetes mellitusAcute complications of diabetes mellitus
Acute complications of diabetes mellitus
 
Ueda2016 symposium - managing special population in diabetic patient,vildagli...
Ueda2016 symposium - managing special population in diabetic patient,vildagli...Ueda2016 symposium - managing special population in diabetic patient,vildagli...
Ueda2016 symposium - managing special population in diabetic patient,vildagli...
 
Healthy Effects Of Quercetin
Healthy Effects Of QuercetinHealthy Effects Of Quercetin
Healthy Effects Of Quercetin
 
The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...
The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...
The Role of Adiponectin in Obesity and its Clinical Utility in Obesity-Associ...
 
antidiabetic and hypoglycemic effect of isolated flavonoids from ficus racemo...
antidiabetic and hypoglycemic effect of isolated flavonoids from ficus racemo...antidiabetic and hypoglycemic effect of isolated flavonoids from ficus racemo...
antidiabetic and hypoglycemic effect of isolated flavonoids from ficus racemo...
 
Achieving Hba1c targets: Strategies For Initiating and Intensifying Diabetes ...
Achieving Hba1c targets: Strategies For Initiating and Intensifying Diabetes ...Achieving Hba1c targets: Strategies For Initiating and Intensifying Diabetes ...
Achieving Hba1c targets: Strategies For Initiating and Intensifying Diabetes ...
 
H032046050
H032046050H032046050
H032046050
 
RECENT ADVANCES IN TREATMENT OF DIABETES MELLITUS
RECENT ADVANCES IN TREATMENT OF DIABETES MELLITUS RECENT ADVANCES IN TREATMENT OF DIABETES MELLITUS
RECENT ADVANCES IN TREATMENT OF DIABETES MELLITUS
 
Management of Diabetes in Dialysis Patients
Management of Diabetes in Dialysis PatientsManagement of Diabetes in Dialysis Patients
Management of Diabetes in Dialysis Patients
 
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity SurgeryResolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
 
Diabetes Emergency.pdf
Diabetes Emergency.pdfDiabetes Emergency.pdf
Diabetes Emergency.pdf
 
Type 2 DM and CKD
Type 2 DM and CKDType 2 DM and CKD
Type 2 DM and CKD
 

Mehr von Aziza Qadeer

Professional_Med_J_Q_2015_22_6_745_751
Professional_Med_J_Q_2015_22_6_745_751Professional_Med_J_Q_2015_22_6_745_751
Professional_Med_J_Q_2015_22_6_745_751
Aziza Qadeer
 
Molecular and Cellular Biochemistry
Molecular and Cellular BiochemistryMolecular and Cellular Biochemistry
Molecular and Cellular Biochemistry
Aziza Qadeer
 
Evaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patientsEvaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patients
Aziza Qadeer
 
article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)
Aziza Qadeer
 
ALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCERALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCER
Aziza Qadeer
 
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-61130-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
Aziza Qadeer
 
hepatotoxicity all (1)
hepatotoxicity all (1)hepatotoxicity all (1)
hepatotoxicity all (1)
Aziza Qadeer
 

Mehr von Aziza Qadeer (13)

Uzma
UzmaUzma
Uzma
 
SXGYFL
SXGYFLSXGYFL
SXGYFL
 
SbCtyB
SbCtyBSbCtyB
SbCtyB
 
Professional_Med_J_Q_2015_22_6_745_751
Professional_Med_J_Q_2015_22_6_745_751Professional_Med_J_Q_2015_22_6_745_751
Professional_Med_J_Q_2015_22_6_745_751
 
Paper-19
Paper-19Paper-19
Paper-19
 
Molecular and Cellular Biochemistry
Molecular and Cellular BiochemistryMolecular and Cellular Biochemistry
Molecular and Cellular Biochemistry
 
HPshjg (2)
HPshjg (2)HPshjg (2)
HPshjg (2)
 
Fg5V2T
Fg5V2TFg5V2T
Fg5V2T
 
Evaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patientsEvaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patients
 
article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)
 
ALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCERALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCER
 
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-61130-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
 
hepatotoxicity all (1)
hepatotoxicity all (1)hepatotoxicity all (1)
hepatotoxicity all (1)
 

ANTIOXIDANT VITAMINS IN DIABETES

  • 1. Medical Journal of the Islamic Republic ofIran Volwne 13 Nwnber3 Fall 1378 November 1999 ANTIOXIDANT VITAMINS IN DIABETES A. KHANAM, Ph.D. From the Department ofBiochemistry, University ofKarachi, Karachi-75270, Pakistan. ABSTRACT The study included nineteen control subjects and fifty-nine diabetic patients. The diabetic patients were divided according to the treatment they received. Fasting blood glucose was markedly increased in all three groups, while low serum vitamin A, C and E levels were observed in diabetic patients as compared to control subjects. MJIRI, Vol. 13, No.3, 175-177, 1999 INTRODUCTION Diabetes mellitus is a chronic disorder of carbohydrate, fatandproteinmetabolism,characterizedbyan inappropriate elevation of the blood glucose level, for which a relative or absolute lack of insulin is reponsible.1 The role of oxidant stress in the causation of chronic tissue damage is being recognized. Oxidant stress is usually countered by an abundant supply of antioxidants. Vitamin E and C levels are markedly lower in diabetic patients. There is a paradoxical rise in catalase and glutathione peroxidase (Gpx)in diabeticpatients withretinopathy. This may be a compensatory mechanism by the body to prevent tissue damage by increasing thelevels of the two alternative antioxidant enzymes.2 Vitamin A blood concentration was significantly decreased in type-I and increased in type-IT diabetic patients as compared to control subjects.3 In pathologic conditions such as diabetes, oxidative stress causes the level of antioxidants to fall below normal.4 Treatment with antioxidants can reduce both oxidative stress and protein glycation and may help to reduce the risk of developing diabetic complications. Ascorbate has both pro-oxidant andantioxidanteffects in vivo.5 Chronic vitamin C administration has a beneficial effect upon glucose and lipid metabolism in aged non-insulin dependent diabetic patients.6 Vitamin E and C levels are markedly lower in diabetic patients.2 Vitamin E delays the oxidative process which turns cells "rancid" and it prevents oxygen from combining with other substances to form the deadly hydrogen peroxide which hastens the death of a cell. VitaminE administration is useful for the prevention of diabetic complications.7 175 MATERIAL AND METHODS Blood samples from pre-diagnosed diabetic patients were collected after12hours of fasting and discontinuation of antidiabetic drugs. For control, the blood samples were obtained from healthy individuals having no symptoms or history of diabetes. Blood was analyzed for glucose,8 ascorbic acid,9 �-carotene, serum retinol and serum c£­ tocophero1.1o RESULTS The study included 19 controls (10 male, 9 female) having a mean age of 24.5± 0.6 years and mean weight of 60.5±2.2 kg; the prediagnosed 59 diabetic patients (29 male, 30 female) had a mean age of 49.6±1.7 years and mean weight of 65.7±2.3 kg. The diabetic patients showed higher levels of blood glucose and lower levels of blood ascorbic acid and serum �-carotene, retinol and vitamin E as compared to normal control subjects (Table1).Thediabeticpatients werefurther categorized as patients on diet control, patients on oral hypoglycemic drugs, and patients on insulin therapy. All three groups of diabetic patients showed a higher level of blood glucose and lower level of serum �-carotene, retinol and vitamin E, and blood vitamin C as compared to control patients (Table II). DISCUSSION The most common and diagnostic character of diabetic patients is ahighfasting bloodsugar level, i.e.hyperglycemia,
  • 2. Antioxidant Vitamins in Diabetes Table I. Blood glucose, �-carotene, retinol, vitamin C and Vitamin E levels in control and diabetic patients. Group Blood b-Carotene Retinol Vitamin C Vitamin E glucose (mg/L) (mg/L) (mg/dL) (mg/L) (mg/dL) Control 87.05 1.43 0.66 2.96 10.31 ±5.42 ±O.10 ±0.01 ±0.23 ±0.24 (19) (19) (19) (19) (19) Diabetics 262.52* 0.61* 0.33* 1.23* 5.77* ±16.01 ±0.03 ±0.01 ±0.O5 ±0.21 (59) (59) (59) (59) (59) * p<0.05, statistically significant as compared to �ntrol subjects. Table II. Blood glucose, �-carotene, retinol, vitamin C and vitamin E levels in control and diabetic patients according to the method of blood sugar control. Group Blood b-Carotene glucose (mg/L) (mg/dL) Control 87.05 1.43 ±5.42 ±0.09 (19) (19) Patients 242.0* 0.70* on diet ±43.31 ±0.09 control (6) (6) PatientS on 263.37* 0.66* oral hypo- ±27.06 ±0.04 glycemic (27) (27) drugs Patients 249.07* 0.57* on insulin ±17.93 ±0.04 therapy (26) (26) * p<0.05 as compared to control. caused by insufficient availability of insulin or inadequate insulin activity in the body.ll The majorityofdiabetic patients sufferwithneuropathy, nephropathy, and ocular complications. Vitamin A, E and C are antioxidants and their lack may cause many of such complications. Salonen12reported that freeradical stress has a role in the causation of non-insulin dependent diabetes mellitus. Martinolil3 showed that plasma retinol is significantly decreased in insulin dependent diabetic patients while n­ tocopherol is significantly altered in diabetic patients with nephropathy. Cabellerol4 reported that vitamin E supplementation produced a significant improvement in 176 Retinol Vitamin C Vitamin E (mg/L) (mg/dL) (mg/L) 0.66 2.96 10.31 ±0.09 ±0.23 ±0.24 (19) (19) (19) 0.36* 1.14* 6.10* ±0.03 ±0.15 ±0.86 (6) (6) (6) 0.32* 1.35* 6.12* ±0.02 ±0.08 ±0.29 (27) (27) (27) 0.34* 1.13* 5.41* ±0.02 ±0.03 ±0.27 (26) (26) (26) glucose utilization and the hepatic response to insulin in normal and diabetic subjects. The vitamin A level was also significantly lowered as compared to control subjects, comparable to the results of Martinoli.13 In the present study vitamin C and E levels in the blood were lower in diabetic patients as compared to control subjects. Rema et aU had also found similar results. The reason may be that the high glucose concentration reduces D-n-tocopherol binding through mechanisms independent of osmotic effects of sorbitol accumulation in the cell. A glucosemediatedreductionin D-n-tocopherolbindingcould diminish the beneficial effects of D-n-tocopherol on the vascular toxicity of hyperglycemia in diabetes mellitus.IS
  • 3. A. Khanam, Ph.J? It is concluded that diabetic patients having elevated fasting blood glucose levels are at risk of lack ofantioxidant vitamins, and the deficiency of these vitamins may lead to further complications. It is therefore recommended that diabeticpatients consume dietswhich are richinantioxidant vitamins. REFERENCES 1. GenuthS: A case for blood glucosecontrol. Adv Int Med 40: 573-623,1995. 2. Rema M,Mohan V,Bhashar A,Shanmugasundarm KR:Does oxidant stress play a role in diabetic retinopathy? Indian J OphthalmoI43(1): 17-21,1995. 3. Krempf M,Ranganthan S,Ritz P,Marin M,Charbonnel B: Plasma vitamin A and E in type-I and type-II adult diabetic patients. IntJ Vitam Nutr Res 61(1): 8-12,1991. 4. Sardesai V M:Role of antioxidants in healthmaintenance.Nutr Clin Pract 10 (1): 19-25,1995. 5. YoungIS,TateS,LightbodyJ H,McMasterD,TrimpleR: The effect of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free-Radic Bio Med 18 (5): 833-834,1995. 6. Paolisso G,Balibo V,Volpe C,Varricchio G,Gambardella A, Saccomanno F,Ammondola S,Varricchio M,D'Onofrio F: Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetes. J Am CoIl Nutr 14(4); 387-392,1995. 7. Ceriello A,Gingliano D,Quatrano A,Donzell C,Dipalo G, 177 Lefebvre PJ: Vitamin E reduction of protein glycosylation in diabetes. New prospects for prevention of diabetic complications. Diabetes Care 14(1): 68-72,1991. . 8. Dubowski K M: An O-toluidine method for body fluidglucose det�rmination. Clin Chern 8: 215-235,1962. 9. Vadey H: Practical Biochemistry,4th ed. Published by Gulab Vam-ani for Arnold-Heinemann,New Delhi,1969. 10. McMurrayW, Gowenlock A H: Vitamins. In: GowenlockAI:J, McMurray JR, Malauchan DM, (eds.), Varley's Practical Clinical Biochemistry. 6th ed,London: Heinemann Medical Books, pp. 895,902,1988. 11. Jamal S: Etiology of diabetes. Diabetes Digest 2(i): 11-15, 1989. 12. Salonen IT, Nyyssonen K, Tuomoinen TP, Maenpaa PH, Koipela H,Kaplan GA, Lynch J,Helmrich SP,Salonen R: Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentration. Br Med J 311 (7013): 1124-1127,1995. 13. Martinoli L,Di Felice M,Seghieri G,Ciuti M,De Giorgoi LA, FazZini A,Gori R,AnichiniR,Franconi F: Plasma retinol and a-tocopherol concentrations in insulin dependent diabetes mellitus: their relationship to microvascular complications. IntJ Vit NutrRes 63(2): 87-92,1993. 14. Cabellero B: Vitamin E improves the action of insulin. Nutr Rev. 51 (11): 339-340,1993. 15. Kunisaki M,Umeda F,Yamauchi T,Masakado M,Nawata H: High glucose reduces specific binding for D-a-tocopherol in cultural aortic endothelial cells. Diabetes 42(8): 1138-1146, 1993.